T1	p 74 82	patients
T2	p 88 140	chemotherapy-induced painful peripheral neuropathy :
T3	p 277 278	.
T4	p 468 497	8 National Cancer Institute (
T5	p 547 609	enrolled 231 patients who were 25 years or older being treated
T6	p 613 622	community
T7	p 627 680	academic settings between April 2008 and March 2011 .
T8	p 701 722	completed July 2012 .
T9	p 763 781	comorbid pain risk
T10	p 784 792	patients
T11	p 934 939	grade
T12	p 1046 1053	least 4
T13	p 1567 1573	pain .
T14	p 1668 1680	representing
T15	p 1745 1777	Individuals receiving duloxetine
T16	p 1923 1928	those
T17	p 2108 2129	Fifty-nine percent of
T18	p 2283 2325	patients with painful chemotherapy-induced
T19	i 16 26	duloxetine
T20	i 88 108	chemotherapy-induced
T21	i 316 331	duloxetine , 60
T22	i 430 448	placebo-controlled
T23	i 498 503	NCI )
T24	i 737 753	chemotherapeutic
T25	i 820 893	either duloxetine followed by placebo or placebo followed by duloxetine .
T26	i 988 1019	NCI Common Terminology Criteria
T27	i 1133 1187	paclitaxel , other taxane , or oxaliplatin treatment .
T28	i 1244 1245	1
T29	i 1273 1300	mg of duloxetine or placebo
T30	i 1348 1381	mg of duloxetine or placebo daily
T31	i 1461 1471	duloxetine
T32	i 1501 1508	placebo
T33	i 1767 1777	duloxetine
T34	i 1942 1949	placebo
T35	i 2050 2072	duloxetine and placebo
T36	i 2156 2166	duloxetine
T37	i 2204 2211	placebo
T38	i 2305 2325	chemotherapy-induced
T39	i 2361 2371	duloxetine
T40	i 2386 2393	placebo
T41	o 30 67	pain , function , and quality of life
T42	o 346 369	average pain severity .
T43	o 502 503	)
T44	o 763 781	comorbid pain risk
T45	o 940 944	1 or
T46	o 952 970	sensory neuropathy
T47	o 988 1042	NCI Common Terminology Criteria for Adverse Events and
T48	o 1099 1124	chemotherapy-induced pain
T49	o 1544 1554	peripheral
T50	o 1567 1587	pain . Pain severity
T51	o 1617 1660	Pain Inventory-Short Form average pain item
T52	o 1684 1688	pain
T53	o 1837 1855	in average pain of
T54	o 2005 2015	difference
T55	o 2023 2049	average pain score between
T56	o 2231 2251	pain of any amount .
T57	o 2337 2349	neuropathy ,
T58	o 2428 2445	reduction in pain